Abdul-Ghani M, Hartman KL, Ngsee JK (2005) Abstrakt interacts with and regulates the expression of sorting nexin-2. J Cell Physiol 204:210–218. https://doi.org/10.1002/jcp.20285

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bourgeois CF, Mortreux F, Auboeuf D (2016) The multiple functions of RNA helicases as drivers and regulators of gene expression. Nat Rev Mol Cell Biol 17:426–438. https://doi.org/10.1038/nrm.2016.50

Article  CAS  PubMed  Google Scholar 

Chlon TM, Stepanchick E, Hershberger CE, Daniels NJ, Hueneman KM, Kuenzi Davis A, Choi K, Zheng Y, Gurnari C, Haferlach T, Padgett RA, Maciejewski JP, Starczynowski DT (2021) Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Cell Stem Cell 28:1966–1981 e6. https://doi.org/10.1016/j.stem.2021.08.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diness BR, Risom L, Frandsen TL, Hansen B, Andersen MK, Schmiegelow K, Wadt KAW (2018) Putative new childhood leukemia cancer predisposition syndrome caused by germline bi-allelic missense mutations in DDX41. Genes Chromosomes Cancer 57:670–674. https://doi.org/10.1002/gcc.22680

Article  CAS  PubMed  Google Scholar 

Gahl WA, Markello TC, Toro C, Fajardo KF, Sincan M, Gill F, Carlson-Donohoe H, Gropman A, Pierson TM, Golas G, Wolfe L, Groden C, Godfrey R, Nehrebecky M, Wahl C, Landis DM, Yang S, Madeo A, Mullikin JC, Boerkoel CF, Tifft CJ, Adams D (2012) The National Institutes of Health Undiagnosed diseases Program: insights into rare diseases. Genet Med 14:51–59. https://doi.org/10.1038/gim.0b013e318232a005

Article  CAS  PubMed  Google Scholar 

Gahl WA, Mulvihill JJ, Toro C, Markello TC, Wise AL, Ramoni RB, Adams DR, Tifft CJ, Udn (2016) The NIH Undiagnosed Diseases Program and Network: applications to modern medicine. Mol Genet Metab 117:393–400. https://doi.org/10.1016/j.ymgme.2016.01.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomez-Puerto MC, Iyengar PV, Garcia de Vinuesa A, Ten Dijke P, Sanchez-Duffhues G (2019) Bone morphogenetic protein receptor signal transduction in human disease. J Pathol 247:9–20. https://doi.org/10.1002/path.5170

Article  CAS  PubMed  Google Scholar 

Idolazzi L, Ridolo E, Fassio A, Gatti D, Montagni M, Caminati M, Martignago I, Incorvaia C, Senna G (2017) Periostin: the bone and beyond. Eur J Intern Med 38:12–16. https://doi.org/10.1016/j.ejim.2016.11.015

Article  CAS  PubMed  Google Scholar 

Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, Bradding P, Fahy JV, Woodruff PG, Harris JM, Arron JR, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma Study G (2012) Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 130:647–654e10. https://doi.org/10.1016/j.jaci.2012.06.025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang Y, Zhu Y, Qiu W, Liu YJ, Cheng G, Liu ZJ, Ouyang S (2017) Structural and functional analyses of human DDX41 DEAD domain. Protein Cell 8:72–76. https://doi.org/10.1007/s13238-016-0351-9

Article  PubMed  Google Scholar 

Kim K, Ong F, Sasaki K (2023) Current understanding of DDX41 mutations in myeloid neoplasms. Cancers (Basel) 15. https://doi.org/10.3390/cancers15020344

Lewinsohn M, Brown AL, Weinel LM, Phung C, Rafidi G, Lee MK, Schreiber AW, Feng J, Babic M, Chong CE, Lee Y, Yong A, Suthers GK, Poplawski N, Altree M, Phillips K, Jaensch L, Fine M, D’Andrea RJ, Lewis ID, Medeiros BC, Pollyea DA, King MC, Walsh T, Keel S, Shimamura A, Godley LA, Hahn CN, Churpek JE, Scott HS (2016) Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. Blood 127:1017–1023. https://doi.org/10.1182/blood-2015-10-676098

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Wang K (2017) InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet 100:267–280. https://doi.org/10.1016/j.ajhg.2017.01.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linder P, Fuller-Pace FV (2013) Looking back on the birth of DEAD-box RNA helicases. Biochim Biophys Acta 1829:750–755. https://doi.org/10.1016/j.bbagrm.2013.03.007

Article  CAS  PubMed  Google Scholar 

Ma JX, Li JY, Fan DD, Feng W, Lin AF, Xiang LX, Shao JZ (2018) Identification of DEAD-Box RNA helicase DDX41 as a trafficking protein that involves in multiple innate Immune Signaling pathways in a zebrafish model. Front Immunol 9:1327. https://doi.org/10.3389/fimmu.2018.01327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maciejewski JP, Padgett RA, Brown AL, Muller-Tidow C (2017) DDX41-related myeloid neoplasia. Semin Hematol 54:94–97. https://doi.org/10.1053/j.seminhematol.2017.04.007

Article  PubMed  PubMed Central  Google Scholar 

Makishima H, Saiki R, Nannya Y, Korotev S, Gurnari C, Takeda J, Momozawa Y, Best S, Krishnamurthy P, Yoshizato T, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Nagata Y, Kakiuchi N, Onizuka M, Chiba K, Tanaka H, Kon A, Ochi Y, Nakagawa MM, Okuda R, Mori T, Yoda A, Itonaga H, Miyazaki Y, Sanada M, Ishikawa T, Chiba S, Tsurumi H, Kasahara S, Muller-Tidow C, Takaori-Kondo A, Ohyashiki K, Kiguchi T, Matsuda F, Jansen JH, Polprasert C, Blombery P, Kamatani Y, Miyano S, Malcovati L, Haferlach T, Kubo M, Cazzola M, Kulasekararaj AG, Godley LA, Maciejewski JP, Ogawa S (2023) Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood 141:534–549. https://doi.org/10.1182/blood.2022018221

Article  CAS  PubMed  Google Scholar 

Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S, Toda S, Inagaki N, Kurihara Y, Hayashida S, Takeuchi S, Koike K, Ono J, Noshiro H, Furue M, Conway SJ, Narisawa Y, Izuhara K (2012) Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 122:2590–2600. https://doi.org/10.1172/JCI58978

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, Iyer SS, Zaver SA, Schenk M, Zeng S, Zhong W, Liu ZJ, Modlin RL, Liu YJ, Cheng G (2012) The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 13:1155–1161. https://doi.org/10.1038/ni.2460

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peters D, Radine C, Reese A, Budach W, Sohn D, Janicke RU (2017) The DEAD-box RNA helicase DDX41 is a novel repressor of p21(WAF1/CIP1) mRNA translation. J Biol Chem 292:8331–8341. https://doi.org/10.1074/jbc.M116.772327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, Singh J, Padgett RA, Gu X, Phillips JG, Clemente M, Parker Y, Lindner D, Dienes B, Jankowsky E, Saunthararajah Y, Du Y, Oakley K, Nguyen N, Mukherjee S, Pabst C, Godley LA, Churpek JE, Pollyea DA, Krug U, Berdel WE, Klein HU, Dugas M, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Yoshida K, Ogawa S, Muller-Tidow C, Maciejewski JP (2015) Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell 27:658–670. https://doi.org/10.1016/j.ccell.2015.03.017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Putnam AA, Jankowsky E (2013) DEAD-box helicases as integrators of RNA, nucleotide and protein binding. Biochim Biophys Acta 1829:884–893. https://doi.org/10.1016/j.bbagrm.2013.02.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP (2019) DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease. Am J Hematol 94:757–766. https://doi.org/10.1002/ajh.25486

Article  CAS  PubMed  Google Scholar 

Ratajczak-Wielgomas K, Dziegiel P (2015) The role of periostin in neoplastic processes. Folia Histochem Cytobiol 53:120–132. https://doi.org/10.5603/FHC.a2015.0014

Article  CAS  PubMed  Google Scholar 

Sebert M, Passet M, Raimbault A, Rahme R, Raffoux E, Sicre de Fontbrune F, Cerrano M, Quentin S, Vasquez N, Da Costa M, Boissel N, Dombret H, Peffault de Latour R, Socie G, Itzykson R, Fenaux P, Soulier J, Ades L, Clappier E (2019) Germline DDX41 mutations define a significant entity within adult MDS/AML patients. Blood 134:1441–1444. https://doi.org/10.1182/blood.2019000909

Article